Ketonite Cream contains Ketoconazole 1% w/w, an imidazole antifungal agent effective in the treatment of various superficial fungal infections of the skin. Ketoconazole acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Ketonite Cream is indicated for the topical management of dermatophytosis, candidiasis, and pityriasis versicolor. It is suitable for application on affected areas such as the body, face, and scalp, providing targeted antifungal activity with minimal systemic absorption. The cream formulation allows for easy application and good skin penetration, enhancing therapeutic outcomes. Patients are advised to apply a thin layer of Ketonite Cream to the affected area once or twice daily, depending on the severity of infection and as directed by a healthcare professional. Treatment duration typically ranges from 2 to 4 weeks but may vary based on clinical response. Ketonite Cream is generally well tolerated; however, mild local irritation, burning, or itching may occur. It is contraindicated in individuals with known hypersensitivity to ketoconazole or any cream excipients. Use during pregnancy and lactation should be under medical supervision. Proper adherence to treatment and hygiene measures is essential to prevent recurrence.